DermTech, Inc. (DMTK): Price and Financial Metrics
DMTK Price/Volume Stats
| Current price | $0.09 | 52-week high | $3.90 |
| Prev. close | $0.11 | 52-week low | $0.09 |
| Day low | $0.09 | Volume | 3,662,300 |
| Day high | $0.10 | Avg. volume | 1,065,175 |
| 50-day MA | $0.44 | Dividend yield | N/A |
| 200-day MA | $1.08 | Market Cap | 3.29M |
DMTK Stock Price Chart Interactive Chart >
DermTech, Inc. (DMTK) Company Bio
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive diagnostic tests to diagnosis skin cancer and related conditions in the United States. The company offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. It also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. The company is also developing non-melanoma skin cancer diagnostic and non-melanoma skin cancer risk assessment products. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
DMTK Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -20.77% |
| 1-year | -94.27% |
| 3-year | -99.49% |
| 5-year | -99.27% |
| YTD | -94.86% |
| 2023 | -1.13% |
| 2022 | -88.80% |
| 2021 | -51.29% |
| 2020 | 161.61% |
| 2019 | -39.28% |
Loading social stream, please wait...